NASDAQ · Biotechnology

Applied Genetic Technologies Corporation (AGTC) Stock

$0.39 +0.00% NASDAQ: AGTC Healthcare

Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets.

Valuation

MetricValue
Price$0.39
Market Cap$0
P/E Ratio-0.25
P/B Ratio0.60
P/S Ratio0.00
EPS (TTM)$-1.59
52-Week High$2.83
52-Week Low$0.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-244.83%
ROA-105.97%
ROCE-159.77%
Gross Margin100.00%
Operating Margin—
Net Margin—
Debt/Equity0.76
Current Ratio2.00

Annual Financials (USD)

Metric20182019202020212022
Revenue$24.0M$42.0M$2.0M$1.0M$0
Operating Profit$-22.0M$-4.0M$-47.0M$-58.0M$-66.0M
Net Profit$-21.0M$-2.0M$-46.0M$-58.0M$-71.0M
EPS$-1.18$-0.11$-2.17$-1.77$-1.59
Op Margin-92.5%-10.4%-1913.7%-11690.2%-20390.5%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$119.0M$92.0M$100.0M$127.0M$67.0M
Total Liabilities$19.0M$14.0M$29.0M$41.0M$37.0M
Cash$31.0M$27.0M$38.0M$105.0M$46.0M
Borrowings$0$0$11.0M$24.0M$22.0M

Latest News

Vallourec to supply pipes for Atapu 2 offshore project in Brazil Offshore Technology · Jul 23, 2026 Micron and Sandisk Are Surging: Can the Rally Last Through 2027? Motley Fool · Jul 23, 2026 1 Dow Jones Stock with Exciting Potential and 2 Facing Headwinds StockStory · Jul 23, 2026 Solowin Expands FinTech Network, Enters Latin American Market MT Newswires · Jul 23, 2026 CRIF India Launches Chennai Chapter of 'Credit Goes to HER' to Strengthen Women's Leadership in the Credit Ecosystem PR Newswire · Jul 23, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-33.0M$-23.0M$-42.0M$-51.0M$-66.0M
Investing Cash Flow$32.0M$19.0M$7.0M$36.0M$-2.0M
Financing Cash Flow$0$0$45.0M$80.0M$7.0M
Net Cash Flow$0$-4.0M$12.0M$67.0M$-59.0M
Free Cash Flow$-33.0M$-24.0M$-43.0M$-53.0M$-68.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA0.37
FCF Yield—
Quick Ratio1.97
Interest Coverage-24.78
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLKAllakos Inc. $0.33 +0.22% -0.25 $29.74M 0.00%
ANGNAngion Biomedica Corp. $1.00 +0.00% -0.42 $30.11M 0.00%
AXLAAxcella Health Inc. $4.58 +0.00% -3.61 $12.50M 0.00%
ELEVElevation Oncology, Inc. $0.37 -2.12% -0.47 $21.63M 0.00%
FRLNFreeline Therapeutics Holdings plc $6.49 +0.15% -0.29 $28.28M 0.00%

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets. These encompass treatments for X-linked retinitis pigmentosa and achromatopsia, both currently undergoing Phase 1/2 clinical trials. Additionally, an optogenetic therapy candidate is in development to tackle advanced retinal conditions. Beyond its ophthalmic initiatives, AGTC is advancing several preclinical programs. These early-stage endeavors include a program for otology (ear disorders), another for dry age-related macular degeneration, and two targeting central nervous system disorders like frontotemporal dementia and amyotrophic lateral sclerosis. The company maintains strategic partnerships with entities such as the University of Florida, Bionic Sight, Inc., and Otonomy, Inc. Founded in 1999, AGTC's operations are based out of its headquarters in Alachua, Florida.

the stock is valued at a price-to-earnings (P/E) ratio of -0.25, price-to-book of 0.60, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.23 and $2.83, and currently trades 86.2% below its 52-week high.

On profitability, Applied Genetic Technologies Corporation generates a return on equity (ROE) of -244.83%, return on capital employed of -159.77%.

Official website: agtc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides